Learn More
Invitrogen™ TEM7 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5113897
Description
Immunogen sequence: MDTLPDNRTR VVEDNHSYYV SRLYGPSEPH SRELWVDVAE ANRSQVKIHT For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles. Predicted homology: Cow: 93%; Dog: 100%; Guinea Pig: 85%; Horse: 86%; Human: 100%; Mouse: 100%; Rabbit: 93%; Rat: 100%.
Recently, using SAGE (Serial Analysis of Gene Expression) technology, St. Croix et al, have identified 46 genes, whose expression is specifically elevated in tumor-associated endothelium. Nine of these genes were prominently expressed only in tumor endothelial cells (EC), but were absent or barely detectable in normal ECs, and named as Tumor Endothelial Markers (TEMs, TEM 1-9). TEM7 (Tumor endothelial marker 7) transcripts are specifically expressed in the endothelium of colorectal cancer, primary cancers of lung, pancreas, breast, and brain. TEM7 is expressed specifically in endothelium of these cancers, whether primary or metastasis. The other six members of this family (TEM1, 3, 4, 5, 8, and 9) also show similar expression pattern in lung and brain tumors, and liver metastasis. Since most of the genes expressed differentially in tumor endothelium are also expressed during angiogenesis, these newly discovered genes might provide important resources for basic and clinical studies of human angiogenesis.
Specifications
TEM7 | |
Polyclonal | |
Unconjugated | |
PLXDC1 | |
2410003I07Rik; ADP-ribosylation factor-like 12; AI848450; Arl12; DKFZp686F0937; FLJ36270; FLJ45632; plexin domain containing 1; plexin domain-containing protein 1; PLXDC1; TEM3; TEM7; TEM7 related; tumor endothelial marker 3; Tumor endothelial marker 7; tumor endothelial marker7 | |
Rabbit | |
Affinity chromatography | |
RUO | |
57125 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.5 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
Q8IUK5 | |
PLXDC1 | |
Synthetic peptide directed towards the N terminal region of human PLXDC1 (aa 74-123). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
Your input is important to us. Please complete this form to provide feedback related to the content on this product.